Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Guard Therapeutics

1.60 SEK

+1.59 %

Less than 1K followers

GUARD

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Guard Therapeutics

2019202020212022202320242025
Revenue
growth-%
EBITDA-43.6-40.1-81.9-114.9-115.1-99.9-
EBIT-44.3-40.3-81.9-114.9-115.1-99.9-107.2
Profit before taxes-45.2-40.3-82.0-112.8-113.3-96.1-108.9
Net income-45.2-40.3-82.0-112.8-113.3-96.1-108.9
EPS-13.73-12.53-17.63-15.34-10.80-8.27-6.04
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%
EBIT-%
ROE-100.5 %-50.6 %-46.7 %-63.6 %-169.8 %-253.0 %-267.9 %
ROI-80.7 %-44.2 %-43.1 %-55.7 %-133.0 %-172.4 %-201.0 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.